{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:01:25Z","timestamp":1785819685021,"version":"3.56.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009230","name":"Uppsala County Council","doi-asserted-by":"crossref","award":["41403"],"award-info":[{"award-number":["41403"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009230","name":"Uppsala County Council","doi-asserted-by":"crossref","award":["42309"],"award-info":[{"award-number":["42309"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009230","name":"Uppsala County council","doi-asserted-by":"crossref","award":["1040311"],"award-info":[{"award-number":["1040311"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Persistent symptoms attributed to presumed tick-bite exposure constitute an unresolved medical controversy. We evaluated whether Swedish adults who met the criteria for post-treatment Lyme disease syndrome (PTLDS) exhibited characteristics distinguishable from adults who did not, but who displayed similar symptoms and disease course after suspected previous tick-bite infection (TBI).<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods and findings<\/jats:title><jats:p>During 2015\u20132018, 255 patients\u2013referred to the Centre for Vector-borne Infections, Uppsala University Hospital, Sweden with symptoms lasting longer than six months\u2013were recruited. Of this group, 224 completed the study. Each patient was examined by an infectious disease specialist and, besides a full medical history, underwent a panel of blood and cerebrospinal fluid laboratory tests including hematological, biochemical, microbiological and immunological analyses, and the RAND-36 scale to measure quality of life. For analysis purposes, patients were divided into five subgroups, of which one represented PTLDS. According to serological results indicating TBI and documented\/ reported objective signs of Lyme disease, 85 (38%) patients fulfilled the criteria for PTLDS and were compared with the other 139 (62%) serologically classified patients. In the PTLDS group, erythema chronicum migrans (ECM) was documented\/reported in 86% of patients, previous neuroborreliosis in 15%, and acrodermatitis chronica atroficans (ACA) in 3.5%. However, there were no significant differences regarding symptoms, laboratory results or disease course between patients with PTLDS and those without laboratory evidence of<jats:italic>Borrelia<\/jats:italic>exposition. Most reported symptoms were fatigue-related (70%), musculoskeletal (79%), neurological (82%) and neurocognitive (57%). Tick bites were recalled by 74%. The RAND-36 score was significantly below that of the general Swedish population. Signs of immunological\/inflammatory reactivity with myositis antibodies were detected in 20% of patients, fibrinogen levels were moderately increased in 21% and elevated rheumatoid factor in 6%.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Conclusions<\/jats:title><jats:p>The PTLDS group did not differ exclusively in any respect from the other subgroups, which either lacked previously documented\/reported evidence of borreliosis or even lacked detectable serological signs of exposure to Lyme disease. The results suggest that symptoms often categorized as Chronic-Lyme-Disease (CLD) in the general debate, cannot be uniquely linked to Lyme disease. However, approximately 20% of the total group of patients showed signs of autoimmunity. Further studies are needed to elucidate the underlying causes and mechanisms of PTLDS and there is reason to consider a multifactorial approach.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0247384","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:55:33Z","timestamp":1616090133000},"page":"e0247384","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0093-5725","authenticated-orcid":true,"given":"Kenneth","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Skoog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-5655","authenticated-orcid":true,"given":"Lisa","family":"Labb\u00e9 Sandelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bj\u00f6rling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Fridenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"pone.0247384.ref001","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of chronic Lyme disease","volume":"357","author":"HM Feder","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0247384.ref002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"341","author":"AC Steere","year":"2001","journal-title":"N Eng J Med"},{"key":"pone.0247384.ref003","first-page":"151","article-title":"The role of particular ticks [sic] developmental stages in the circulation of tick-borne pathogens in Central Europe. 5. Borreliaceae","volume":"64","author":"G Karbowiak","year":"2018","journal-title":"Ann Parasitol"},{"key":"pone.0247384.ref004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe","volume":"17","author":"G Stanek","year":"2011","journal-title":"Clin Microbiol Inf"},{"key":"pone.0247384.ref005","first-page":"1392","article-title":"Clinical and neurocognitive features of the post Lyme syndrome","volume":"23","author":"DI Bujak","year":"1996","journal-title":"J Rheumatol"},{"key":"pone.0247384.ref006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2296-15-79","article-title":"Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study","volume":"15","author":"A Ali","year":"2014","journal-title":"BMC Family Practice"},{"key":"pone.0247384.ref007","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1468-1331.2012.03691.x","article-title":"The phenomenon of chronic Lyme; an observational study","volume":"19","author":"U Lj\u00f8stad","year":"2012","journal-title":"Eur J Neurology"},{"key":"pone.0247384.ref008","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMe1502350","article-title":"Time for a different approach to Lyme disease and long-term symptoms","volume":"374","author":"MT Melia","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0247384.ref009","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MOP.0000000000000167","article-title":"Update on persistent symptoms associated with Lyme disease","volume":"27","author":"CR Oliviera","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"pone.0247384.ref010","first-page":"w14353","article-title":"Update on the Swiss guidelines on post-treatment Lyme disease syndrome","volume":"146","author":"J Nemeth","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"pone.0247384.ref011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"MS Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"pone.0247384.ref012","doi-asserted-by":"crossref","first-page":"264. e1","DOI":"10.1016\/j.amjmed.2012.10.008","article-title":"Common misconceptions about Lyme disease","volume":"126","author":"JJ Halperin","year":"2013","journal-title":"Am J Med"},{"key":"pone.0247384.ref013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/IJGM.S75825","article-title":"Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort","volume":"8","author":"PJ Mayne","year":"2014","journal-title":"Int J Gen Med"},{"key":"pone.0247384.ref014","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis, clinical practice guidelines by the Infectious Disease Society of America","volume":"43","author":"GP Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pone.0247384.ref015","doi-asserted-by":"crossref","first-page":"e0166653","DOI":"10.1371\/journal.pone.0166653","article-title":"Prevalence of Rickettsia spp. in ticks and serological and clinical outcomes in tick-bitten individuals in Sweden and on the \u00c5land Islands","volume":"11","author":"A Lindblom","year":"2016","journal-title":"Plos One"},{"key":"pone.0247384.ref016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13071-017-2042-7","article-title":"Molecular detection of Bartonella henselae in 11 Ixodes ricinus ticks extracted from a single cat","volume":"10","author":"Y Regler","year":"2017","journal-title":"Parasites & Vectors"},{"key":"pone.0247384.ref017","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3201\/eid2108.150060","article-title":"Infections with Candidatus Neoehrlichia mikurensis and Cytokine Responses in 2 Persons Bitten by Ticks, Sweden","volume":"21","author":"A Grankvist","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"pone.0247384.ref018","first-page":"129","article-title":"Precision medicine: The role of the MSDIS model in defining, diagnosing and treating Chronic Lyme Disease\/post treatment Lyme disease syndrome and other chronic illness","volume":"6","author":"RI Horowitz","year":"2018","journal-title":"Part. 2 Healthcare (Basel)."},{"key":"pone.0247384.ref019","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"MB Yunus","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0247384.ref020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"DR Hays","year":"2001","journal-title":"Annals of Medicine"},{"key":"pone.0247384.ref021","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0895-4356(98)00102-4","article-title":"The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population","volume":"51","author":"M Sullivan","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"pone.0247384.ref022","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Y Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"pone.0247384.ref023","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4269\/ajtmh.2005.73.1083","article-title":"A highly sensitive and specific real-time PCR assay for the detection of spotted fever and typhus group rickettsiae","volume":"73","author":"J Stenos","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0247384.ref024","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"AC Steere","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0247384.ref025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/NAN.0000000000000195","article-title":"Controversies in persistent (chronic) Lyme disease","volume":"39","author":"EL Maloney","year":"2016","journal-title":"J Infus Nurs"},{"key":"pone.0247384.ref026","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/1049732315619380","article-title":"Living in limbo: Contested Narratives of patients with chronic symptoms following Lyme disease","volume":"27","author":"AW Rebman","year":"2017","journal-title":"Qualitative Health Research"},{"key":"pone.0247384.ref027","first-page":"1441","article-title":"Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi","volume":"319","author":"RJ Dattwyler","year":"1988","journal-title":"N Eng J Med"},{"key":"pone.0247384.ref028","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1002\/art.23135","article-title":"Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis","volume":"56","author":"P Kannian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"pone.0247384.ref029","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/imj.13278","article-title":"Lyme disease: why the controversy?","volume":"46","author":"MH Beaman","year":"2016","journal-title":"Int Med J"},{"key":"pone.0247384.ref030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for Lyme disease","volume":"47","author":"AC Steere","year":"2008","journal-title":"Clin Infect Dis"},{"key":"pone.0247384.ref031","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to Lyme disease","volume":"374","author":"A Berende","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0247384.ref032","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"MS Klempner","year":"2001","journal-title":"N Eng J Med"},{"key":"pone.0247384.ref033","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"ES Asch","year":"1994","journal-title":"J Rheumatol"},{"key":"pone.0247384.ref034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"N Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"pone.0247384.ref035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnette","year":"1988","journal-title":"Atrhritis Rheum"},{"key":"pone.0247384.ref036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","article-title":"Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies","volume":"9","author":"J R\u00f6nnelid","year":"2009","journal-title":"Autoimmun Rev"},{"key":"pone.0247384.ref037","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","volume":"48","author":"C Bundell","journal-title":"Pathology"},{"key":"pone.0247384.ref038","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(04)16154-0","article-title":"Autoantibodies as predictors of disease","volume":"363","author":"RH Scofield","year":"2004","journal-title":"Lancet"},{"key":"pone.0247384.ref039","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"MR Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0247384.ref040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/rheumatology\/34.10.915","article-title":"Changing autoantibody profiles with variable clinical manifestations in a patient with relapsing systemic lupus erythematosus and polymyositis","volume":"34","author":"M Satoh","year":"1995","journal-title":"Br J Rheumatol"},{"key":"pone.0247384.ref041","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of Patients with posttreatment lyme disease syndrome","volume":"4","author":"AW Rebman","year":"2017","journal-title":"Front Med"},{"key":"pone.0247384.ref042","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cpr.2007.07.004","article-title":"Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts","volume":"27","author":"K Roelofs","year":"2007","journal-title":"Clinical Psychology review"},{"key":"pone.0247384.ref043","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.rmed.2006.10.014","article-title":"Gender and age differences in the relative burden of rhinitis and asthma on health-related quality of life- a Swedish population study","volume":"101","author":"U Larsson","year":"2007","journal-title":"Resp Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T15:52:03Z","timestamp":1619711523000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247384"}},"subtitle":[],"editor":[{"given":"Sam R.","family":"Telford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0247384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]}}}